Correction: Safety and efficacy of nemolizumab for patients with pruritus: a systematic review and meta-regression analysis of randomized controlled trial

Puntos clave

• Safety and efficacy findings regarding nemolizumab for pruritus are corrected.
• Previous assessments highlighted the impact on pruritus determined through systematic review and meta-regression analysis.
• Assessment through systematic review and meta-regression covering several randomized controlled trials provides a comprehensive overview.
• Further verification is needed to establish definite protocols, as the significance of findings for clinical practice requires precise scrutiny.